de Jonge MJ - Search Results

1

Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin.

Mathijssen RH, van Alphen RJ, de Jonge MJ, Verweij J, de Bruijn P, Loos WJ, Nooter K, Vernillet L, Stoter G, Sparreboom A. Mathijssen RH, et al. Among authors: de bruijn p, de jonge mj. Anticancer Drugs. 1999 Jan;10(1):9-16. doi: 10.1097/00001813-199901000-00002. Anticancer Drugs. 1999. PMID: 10194542 Clinical Trial.

2

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Gerrits CJ, de Jonge MJ, Schellens JH, Stoter G, Verweij J. Gerrits CJ, et al. Among authors: de jonge mj. Br J Cancer. 1997;76(7):952-62. doi: 10.1038/bjc.1997.491. Br J Cancer. 1997. PMID: 9328159 Free PMC article. Review.

3

Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces.

Sparreboom A, de Bruijn P, de Jonge MJ, Loos WJ, Stoter G, Verweij J, Nooter K. Sparreboom A, et al. Among authors: de bruijn p, de jonge mj. J Chromatogr B Biomed Sci Appl. 1998 Aug 7;712(1-2):225-35. doi: 10.1016/s0378-4347(98)00147-9. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9698245 Clinical Trial.

4

Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumors.

Sparreboom A, de Jonge MJ, Punt CJ, Nooter K, Loos WJ, Porro MG, Verweij J. Sparreboom A, et al. Among authors: de jonge mj. Clin Cancer Res. 1998 Aug;4(8):1915-9. Clin Cancer Res. 1998. PMID: 9717819 Clinical Trial.

5

The development of combination therapy involving camptothecins: a review of preclinical and early clinical studies.

de Jonge MJ, Sparreboom A, Verweij J. de Jonge MJ, et al. Cancer Treat Rev. 1998 Jun;24(3):205-20. doi: 10.1016/s0305-7372(98)90050-0. Cancer Treat Rev. 1998. PMID: 9767735 Review. No abstract available.

6

Irinotecan (CPT-11) metabolism and disposition in cancer patients.

Sparreboom A, de Jonge MJ, de Bruijn P, Brouwer E, Nooter K, Loos WJ, van Alphen RJ, Mathijssen RH, Stoter G, Verweij J. Sparreboom A, et al. Among authors: de bruijn p, de jonge mj. Clin Cancer Res. 1998 Nov;4(11):2747-54. Clin Cancer Res. 1998. PMID: 9829738 Clinical Trial.

7

Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography.

de Bruijn P, de Jonge MJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A. de Bruijn P, et al. Among authors: de jonge mj. Anal Biochem. 1999 Apr 10;269(1):174-8. doi: 10.1006/abio.1999.4001. Anal Biochem. 1999. PMID: 10094790

8

Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva.

de Jonge MJ, Verweij J, Loos WJ, Dallaire BK, Sparreboom A. de Jonge MJ, et al. Clin Pharmacol Ther. 1999 May;65(5):491-9. doi: 10.1016/S0009-9236(99)70068-8. Clin Pharmacol Ther. 1999. PMID: 10340914 Free article. Clinical Trial.

9

Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysis.

Sparreboom A, de Jonge MJ, Punt CJ, Loos WJ, Nooter K, Stoter G, Porro MG, Verweij J. Sparreboom A, et al. Among authors: de jonge mj. Drug Metab Dispos. 1999 Jul;27(7):816-20. Drug Metab Dispos. 1999. PMID: 10383926

10

Drug-administration sequence does not change pharmacodynamics and kinetics of irinotecan and cisplatin.

de Jonge MJ, Verweij J, Planting AS, van der Burg ME, Stoter G, de Boer-Dennert MM, de Bruijn P, Brouwer E, Vernillet L, Sparreboom A. de Jonge MJ, et al. Among authors: de bruijn p, de boer dennert mm. Clin Cancer Res. 1999 Aug;5(8):2012-7. Clin Cancer Res. 1999. PMID: 10473080 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters